Company intelligence / Profile preview

Algaltek

Chavannes-près-Renens, Vaud, Switzerlandalgaltek.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Algaltek has developed and commercialized a modular, automated hybrid algae culture system that combines the precision of closed bioreactors with the scalability of open ponds. The technology maximizes productivity and water efficiency using thin-layer culturing, advanced UV filtering, built-in electricity generation options, and sun-powered operation. It targets sustainable production of algal biomass for various applications.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Algaltek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algaltek.

Explore the full profile